In patients with breast cancer, Sosman et al. [45] demonstrated higher NK cell recovery at day 14 after autologous stem cell transplantation for patients mobilized with interleukin-2 and G-CSF compared with patients mobilized with G-CSF alone. This evidence concerns the gene CSF3 and breast cancer.